Stanley Szefler, MD

Website: http://www.ncbi.nlm.nih.gov/pubmed?term="Szefler SJ"[Author]

For Patients:
Dr. Szefler's major contributions are directed toward the appropriate use of long-term control therapy in asthma, including the recognition of variability in response to asthma therapy. He has identified biomarkers and asthma characteristics that can be used to predict and thus individualize asthma therapy. Dr. Szefler is the Director of the Pediatric Asthma Research Program in the Breathing Institute of the Pediatric Pulmonary Section at Children's Hospital Colorado. He is also Professor of Pediatrics at the University of Colorado Denver School of Medicine. He is also a member of the Expert Panel for the National Heart, Lung, and Blood Institute's National Asthma Education and Prevention Program on "Guidelines for the Diagnosis and Management of Asthma" and a member of the Global Initiative for Asthma Science Committee. Since 1997, he has been a Deputy Editor for the Journal of Allergy and Clinical Immunology. He has published more than 400 scientific articles and co-edited books on severe asthma, childhood asthma and pediatric allergy and immunology. He is the Principal Investigator for the Denver site of the NHLBI AsthmaNet-Pediatrics Section and Co-Investigator for the NIAID Inner-City Asthma Consortium (ICAC) II. He is also a Co-Director for the NIEHS/EPA Childhood Environmental Health Center Grant at National Jewish Health and the University of Colorado Denver. For the past eight years, he has directed a school-based asthma program for the Denver Public School system funded by the Colorado Cancer, Cardiovascular and Pulmonary Disease Program, the Caring for Colorado Foundation, and the McCormick Foundation. This program seeks to define the prevalence and severity of asthma, identify those most significantly affected, and to direct those children to state of the art asthma care. This program is now being developed as a mentorship program supported by Glaxo Smith Kline in order to set a national standard for school-based asthma management.

For Referring Providers:
Dr. Szefler’s major contributions are directed toward the appropriate use of long-term control therapy in asthma, including the recognition of variability in response to asthma therapy. He has identified biomarkers and asthma characteristics that can be used to predict and thus individualize asthma therapy. Dr. Szefler is the Director of the Pediatric Asthma Research Program in the Breathing Institute of the Pediatric Pulmonary Section at Children’s Hospital Colorado. He is also Professor of Pediatrics at the University of Colorado Denver School of Medicine. He is also a member of the Expert Panel for the National Heart, Lung, and Blood Institute’s National Asthma Education and Prevention Program on “Guidelines for the Diagnosis and Management of Asthma” and a member of the Global Initiative for Asthma Science Committee. Since 1997, he has been a Deputy Editor for the Journal of Allergy and Clinical Immunology. He has published more than 400 scientific articles and co-edited books on severe asthma, childhood asthma and pediatric allergy and immunology. He is the Principal Investigator for the Denver site of the NHLBI AsthmaNet-Pediatrics Section and Co-Investigator for the NIAID Inner-City Asthma Consortium (ICAC) II. He is also a Co-Director for the NIEHS/EPA Childhood Environmental Health Center Grant at National Jewish Health and the University of Colorado Denver. For the past eight years, he has directed a school-based asthma program for the Denver Public School system funded by the Colorado Cancer, Cardiovascular and Pulmonary Disease Program, the Caring for Colorado Foundation, and the McCormick Foundation. This program seeks to define the prevalence and severity of asthma, identify those most significantly affected, and to direct those children to state of the art asthma care. This program is now being developed as a mentorship program supported by Glaxo Smith Kline in order to set a national standard for school-based asthma management.